Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PLK2 Antikörper (AA 336-685)

PLK2 Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7169161
  • Target Alle PLK2 Antikörper anzeigen
    PLK2 (Polo-Like Kinase 2 (PLK2))
    Bindungsspezifität
    • 11
    • 9
    • 8
    • 7
    • 6
    • 6
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 336-685
    Reaktivität
    • 56
    • 27
    • 24
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 55
    • 1
    Kaninchen
    Klonalität
    • 56
    Polyklonal
    Konjugat
    • 29
    • 5
    • 4
    • 4
    • 4
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser PLK2 Antikörper ist unkonjugiert
    Applikation
    • 47
    • 36
    • 20
    • 8
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    ELISA, Immunohistochemistry (IHC)
    Kreuzreaktivität
    Human
    Aufreinigung
    Antigen Affinity Purified
    Immunogen
    Recombinant Human Serine/threonine-protein kinase PLK2 protein (336-685AA)
    Isotyp
    IgG
    Top Product
    Discover our top product PLK2 Primärantikörper
  • Applikationshinweise
    Recommended dilution: IHC:1:20-1:200,
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    PLK2 (Polo-Like Kinase 2 (PLK2))
    Andere Bezeichnung
    PLK2 (PLK2 Produkte)
    Synonyme
    SNK antikoerper, hPlk2 antikoerper, hSNK antikoerper, Snk antikoerper, PLK2 antikoerper, Plx2 antikoerper, MGC53990 antikoerper, plk2 antikoerper, zgc:165644 antikoerper, polo like kinase 2 antikoerper, polo-like kinase 2 antikoerper, polo-like kinase 2 L homeolog antikoerper, polo-like kinase 2b (Drosophila) antikoerper, Serine/threonine-protein kinase plk-2 antikoerper, PLK2 antikoerper, Plk2 antikoerper, plk2.L antikoerper, plk2b antikoerper, plk2 antikoerper, plk-2 antikoerper
    Hintergrund

    Background: Tumor suppressor serine/threonine-protein kinase involved in synaptic plasticity, centriole duplication and G1/S phase transition. Polo-like kinases act by binding and phosphorylating proteins are that already phosphorylated on a specific motif recognized by the POLO box domains. Phosphorylates CENPJ, NPM1, RAPGEF2, RASGRF1, SNCA, SIPA1L1 and SYNGAP1. Plays a key role in synaptic plasticity and memory by regulating the Ras and Rap protein signaling: required for overactivity-dependent spine remodeling by phosphorylating the Ras activator RASGRF1 and the Rap inhibitor SIPA1L1 leading to their degradation by the proteasome. Conversely, phosphorylates the Rap activator RAPGEF2 and the Ras inhibitor SYNGAP1, promoting their activity. Also regulates synaptic plasticity independently of kinase activity, via its interaction with NSF that disrupts the interaction between NSF and the GRIA2 subunit of AMPARs, leading to a rapid rundown of AMPAR-mediated current that occludes long term depression. Required for procentriole formation and centriole duplication by phosphorylating CENPJ and NPM1, respectively. Its induction by p53/TP53 suggests that it may participate in the mitotic checkpoint following stress.

    Aliases: hPlk2 antibody, hSNK antibody, PLK-2 antibody, Plk2 antibody, PLK2_HUMAN antibody, Polo like kinase 2 antibody, Polo-like kinase 2 antibody, Serine/threonine protein kinase PLK2 antibody, Serine/threonine protein kinase SNK antibody, Serine/threonine-protein kinase PLK2 antibody, Serine/threonine-protein kinase SNK antibody, Serum Induced Kinase antibody, Serum-inducible kinase antibody, SNK antibody

    UniProt
    Q9NYY3
Sie sind hier: